Skip Navigation

Livestream

Create free account

Pharmaceuticals

Eli Lilly blows past quarterly estimates, posts strong outlook as Zepbound and Mounjaro sales soar

Eli Lilly blows past quarterly estimates, posts strong outlook as Zepbound and Mounjaro sales soar

Annika Kim Constantino12 min ago

Novo Nordisk shares tumble 18% as CEO warns it will get worse before it gets better

Novo Nordisk shares tumble 18% as CEO warns it will get worse before it gets better

Elsa Ohlen5 hours ago

The sectors set to gain from India’s U.S. and EU trade deals

The sectors set to gain from India’s U.S. and EU trade deals

Hugh Leask5 hours ago

U.S. drug pricing headwinds spooking Novo Nordisk investors, says BMO's Evan David Seigerman

U.S. drug pricing headwinds spooking Novo Nordisk investors, says BMO's Evan David Seigerman

Tue, Feb 3rd 2026

Why Pfizer shares are under pressure despite a Q4 earnings beat

Why Pfizer shares are under pressure despite a Q4 earnings beat

Tue, Feb 3rd 2026

Novo Nordisk shares tumble after company warns of sales hit this year

Pharmaceuticals

Novo Nordisk shares tumble after company warns of sales hit this year

Tue, Feb 3rd 2026

Pfizer, Merk report Q4 results: Citi's Geoff Meacham on key takeaways

Pfizer, Merk report Q4 results: Citi's Geoff Meacham on key takeaways

Tue, Feb 3rd 2026

Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook

Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook

Tue, Feb 3rd 2026

Health and Science

Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial

Tue, Feb 3rd 2026

Health and Science

Pfizer beats quarterly estimates despite Covid product decline, reaffirms outlook

Tue, Feb 3rd 2026

Health and Science

Merck tops quarterly estimates, posts modest outlook as generic competition looms

Tue, Feb 3rd 2026

Trending Now

More In Pharmaceuticals

Biotech sector having a healthy pause as fundamentals are not broken, says StemPoint's Michelle Ross

Biotech sector having a healthy pause as fundamentals are not broken, says StemPoint's Michelle Ross

Mon, Feb 2nd 2026

Why AstraZeneca poured billions into China ahead of Monday’s U.S. share listing

Biotech and Pharma

Why AstraZeneca poured billions into China ahead of Monday’s U.S. share listing

Mon, Feb 2nd 2026

Lilly's $3.5B facility to make next-gen GLP-1, promising “even more weight loss”

Biotech and Pharma

Lilly's $3.5B facility to make next-gen GLP-1, promising “even more weight loss”

Sat, Jan 31st 2026

Cramer’s week ahead: Earnings from Eli Lilly, Alphabet and Amazon. Plus, jobs data

Fri, Jan 30th 2026

Health and Science

Eli Lilly CEO: Medicare coverage of obesity drugs could support pill launch

Fri, Jan 30th 2026

This dividend fund is one of Morningstar's best. Top stocks its manager likes

Fri, Jan 30th 2026

Eli Lilly plans $3.5 billion Pennsylvania manufacturing plant for obesity drugs

Health and Science

Eli Lilly plans $3.5 billion Pennsylvania manufacturing plant for obesity drugs

Fri, Jan 30th 2026

Drugmakers Roche and Sanofi talk up their pipelines, as earnings fail to excite

Pharmaceuticals

Drugmakers Roche and Sanofi talk up their pipelines, as earnings fail to excite

Thu, Jan 29th 2026

Baird's Michael Ha on how to navigate health insurance stocks in the current downturn

Closing Bell: Overtime

Baird's Michael Ha on how to navigate health insurance stocks in the current downturn

Tue, Jan 27th 2026

Mizuho's Jared Holz on Trump's Medicare advantage proposal: 'This is just a shock to the system'

Tue, Jan 27th 2026

Health and Science

UnitedHealth posts earnings beat, soft revenue guidance as insurer plots turnaround

Tue, Jan 27th 2026

Bernstein's Wilkes talks the insurance stock sell-off on news of the Medicare pricing remaining steady

Mon, Jan 26th 2026

Hyundai shares fall after Trump says tariffs on South Korean autos, pharma to rise to 25%

Hyundai shares fall after Trump says tariffs on South Korean autos, pharma to rise to 25%

Mon, Jan 26th 2026

Next up in weight loss drugs: More pills, easier access and drug combinations

Health and Science

Next up in weight loss drugs: More pills, easier access and drug combinations

Fri, Jan 23rd 2026

Fresenius CEO on how to fix Europe's 'chronically inefficient' healthcare system

Fresenius CEO on how to fix Europe's 'chronically inefficient' healthcare system

Fri, Jan 23rd 2026

A rundown of who Trump criticized at Davos

Fri, Jan 23rd 2026

B Capital: Pharma and biotech undergoing profound transformation thanks to AI

Fri, Jan 23rd 2026

Closing Bell: Overtime

Baseline characteristics in Moderna cancer vaccine 'misleading': Leerink's Dr. Mani Foroohar

Thu, Jan 22nd 2026

Sanofi CEO Paul Hudson: AI will improve efficiency and change the cost and speed of drug development

Sanofi CEO Paul Hudson: AI will improve efficiency and change the cost and speed of drug development

Thu, Jan 22nd 2026

Another alliance of health care and AI signals why pharma stocks could be back

Another alliance of health care and AI signals why pharma stocks could be back

Tue, Jan 20th 2026

Drug pricing, patent losses, deals: What pharma execs see ahead in the industry

Health and Science

Drug pricing, patent losses, deals: What pharma execs see ahead in the industry

Tue, Jan 20th 2026

Novartis’ U.S. deal could shield it from tariffs, CEO tells CNBC

Wed, Jan 21st 2026

Novartis CEO: Confident we are shielded from any further U.S. tariffs

Tue, Jan 20th 2026

Jim Cramer: The whole Aquestive situation seems very ambiguous

Tue, Jan 20th 2026